An assessment of central-peripheral ventilatory chemoreflex interaction using acid and bicarbonate infusions in humans.

1. The object of this study was to investigate the effect of central chemoreceptor stimulation on the ventilatory responses to peripheral chemoreceptor stimulation. 2. The level of central chemoreceptor stimulation was varied by performing experiments at two different levels of end-tidal CO2 pressur...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí: Clement, I, Pandit, J, Bascom, D, Dorrington, K, O'Connor, D, Robbins, P
Formáid: Journal article
Teanga:English
Foilsithe / Cruthaithe: 1995
_version_ 1826268748158337024
author Clement, I
Pandit, J
Bascom, D
Dorrington, K
O'Connor, D
Robbins, P
author_facet Clement, I
Pandit, J
Bascom, D
Dorrington, K
O'Connor, D
Robbins, P
author_sort Clement, I
collection OXFORD
description 1. The object of this study was to investigate the effect of central chemoreceptor stimulation on the ventilatory responses to peripheral chemoreceptor stimulation. 2. The level of central chemoreceptor stimulation was varied by performing experiments at two different levels of end-tidal CO2 pressure (PCO2). Variations in peripheral chemoreceptor stimulus were achieved by varying arterial pH (at constant end-tidal PCO2) and by varying end-tidal O2 pressure (PO2). 3. Two protocols were each performed on six human subjects. In one protocol ventilatory measurements were made during eucapnia, when the arterial pH was lowered from 7.4 to 7.3. The variation in pH was achieved by the progressive infusion of acid (0.1 M HCl). In the other protocol ventilatory measurements were made during hypercapnia, when the arterial pH was increased from 7.3 to 7.4. The variation in pH was achieved by the progressive infusion of 1.26% NaHCO3. In each protocol ventilatory responses were measured during euoxia (end-tidal PO2, 100 Torr), hypoxia (end-tidal PO2, 50 Torr) and hyperoxia (end-tidal PO2, 300 Torr), with end-tidal PCO2 held constant. 4. The increase in ventilatory sensitivity to arterial pH induced by hypoxia (50 Torr) was not significantly different between protocols (acid protocol, -104 +/- 31 l min-1 (pH unit)-1 vs. bicarbonate protocol, -60 +/- 44 l min-1 (pH unit)-1; mean +/- S.E.M.; not significant (n.s.)). The ventilatory sensitivity to hypoxia at an arterial pH of 7.35 was not significantly different between protocols (acid protocol, 14.7 +/- 3.3 l min-1 vs. bicarbonate protocol, 15.6 +/- 2.4 l min-1; mean +/- S.E.M.; n.s.). The results provide no evidence to suggest that peripheral chemoreflex ventilatory responses are modulated by central chemoreceptor stimulation.
first_indexed 2024-03-06T21:14:21Z
format Journal article
id oxford-uuid:3f4078c2-5697-4b51-9451-b4d22d4075fd
institution University of Oxford
language English
last_indexed 2024-03-06T21:14:21Z
publishDate 1995
record_format dspace
spelling oxford-uuid:3f4078c2-5697-4b51-9451-b4d22d4075fd2022-03-26T14:30:51ZAn assessment of central-peripheral ventilatory chemoreflex interaction using acid and bicarbonate infusions in humans.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:3f4078c2-5697-4b51-9451-b4d22d4075fdEnglishSymplectic Elements at Oxford1995Clement, IPandit, JBascom, DDorrington, KO'Connor, DRobbins, P1. The object of this study was to investigate the effect of central chemoreceptor stimulation on the ventilatory responses to peripheral chemoreceptor stimulation. 2. The level of central chemoreceptor stimulation was varied by performing experiments at two different levels of end-tidal CO2 pressure (PCO2). Variations in peripheral chemoreceptor stimulus were achieved by varying arterial pH (at constant end-tidal PCO2) and by varying end-tidal O2 pressure (PO2). 3. Two protocols were each performed on six human subjects. In one protocol ventilatory measurements were made during eucapnia, when the arterial pH was lowered from 7.4 to 7.3. The variation in pH was achieved by the progressive infusion of acid (0.1 M HCl). In the other protocol ventilatory measurements were made during hypercapnia, when the arterial pH was increased from 7.3 to 7.4. The variation in pH was achieved by the progressive infusion of 1.26% NaHCO3. In each protocol ventilatory responses were measured during euoxia (end-tidal PO2, 100 Torr), hypoxia (end-tidal PO2, 50 Torr) and hyperoxia (end-tidal PO2, 300 Torr), with end-tidal PCO2 held constant. 4. The increase in ventilatory sensitivity to arterial pH induced by hypoxia (50 Torr) was not significantly different between protocols (acid protocol, -104 +/- 31 l min-1 (pH unit)-1 vs. bicarbonate protocol, -60 +/- 44 l min-1 (pH unit)-1; mean +/- S.E.M.; not significant (n.s.)). The ventilatory sensitivity to hypoxia at an arterial pH of 7.35 was not significantly different between protocols (acid protocol, 14.7 +/- 3.3 l min-1 vs. bicarbonate protocol, 15.6 +/- 2.4 l min-1; mean +/- S.E.M.; n.s.). The results provide no evidence to suggest that peripheral chemoreflex ventilatory responses are modulated by central chemoreceptor stimulation.
spellingShingle Clement, I
Pandit, J
Bascom, D
Dorrington, K
O'Connor, D
Robbins, P
An assessment of central-peripheral ventilatory chemoreflex interaction using acid and bicarbonate infusions in humans.
title An assessment of central-peripheral ventilatory chemoreflex interaction using acid and bicarbonate infusions in humans.
title_full An assessment of central-peripheral ventilatory chemoreflex interaction using acid and bicarbonate infusions in humans.
title_fullStr An assessment of central-peripheral ventilatory chemoreflex interaction using acid and bicarbonate infusions in humans.
title_full_unstemmed An assessment of central-peripheral ventilatory chemoreflex interaction using acid and bicarbonate infusions in humans.
title_short An assessment of central-peripheral ventilatory chemoreflex interaction using acid and bicarbonate infusions in humans.
title_sort assessment of central peripheral ventilatory chemoreflex interaction using acid and bicarbonate infusions in humans
work_keys_str_mv AT clementi anassessmentofcentralperipheralventilatorychemoreflexinteractionusingacidandbicarbonateinfusionsinhumans
AT panditj anassessmentofcentralperipheralventilatorychemoreflexinteractionusingacidandbicarbonateinfusionsinhumans
AT bascomd anassessmentofcentralperipheralventilatorychemoreflexinteractionusingacidandbicarbonateinfusionsinhumans
AT dorringtonk anassessmentofcentralperipheralventilatorychemoreflexinteractionusingacidandbicarbonateinfusionsinhumans
AT oconnord anassessmentofcentralperipheralventilatorychemoreflexinteractionusingacidandbicarbonateinfusionsinhumans
AT robbinsp anassessmentofcentralperipheralventilatorychemoreflexinteractionusingacidandbicarbonateinfusionsinhumans
AT clementi assessmentofcentralperipheralventilatorychemoreflexinteractionusingacidandbicarbonateinfusionsinhumans
AT panditj assessmentofcentralperipheralventilatorychemoreflexinteractionusingacidandbicarbonateinfusionsinhumans
AT bascomd assessmentofcentralperipheralventilatorychemoreflexinteractionusingacidandbicarbonateinfusionsinhumans
AT dorringtonk assessmentofcentralperipheralventilatorychemoreflexinteractionusingacidandbicarbonateinfusionsinhumans
AT oconnord assessmentofcentralperipheralventilatorychemoreflexinteractionusingacidandbicarbonateinfusionsinhumans
AT robbinsp assessmentofcentralperipheralventilatorychemoreflexinteractionusingacidandbicarbonateinfusionsinhumans